🇺🇸 FDA
Patent

US 7252929

Methods for identifying alpha PDGFR agonists and antagonists

granted A61KA61K38/00

Quick answer

US patent 7252929 (Methods for identifying alpha PDGFR agonists and antagonists) held by United State of America, As Represented by the Secretary, Dept. of Health and Human Services expires Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United State of America, As Represented by the Secretary, Dept. of Health and Human Services
Grant date
Tue Aug 07 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00